Medpace Holdings is trading at $658.43 (+6.36%) in pre-market, mainly amid broader risk-on sentiment after Nvidia’s strong results.
- No clearly reported company-specific announcement emerged on August 27, 2026.
- Its latest major catalyst was the July 22, 2026, second-quarter report, which showed $707.3 million in revenue and raised guidance.
- S&P 500 futures rose 0.39% and Nasdaq futures 0.84%; the move exceeds recent daily gains.